High-Output Heart Failure in Multiple Myeloma: Novel Application of Tc-99m MAA to Identify Intramedullary Shunting

Enklajd Marsela, Eric Hirsch, Leandro Slipczuk, Mark I. Travin, Renee M. Moadel, Ulrich P. Jorde, Sasa Vukelic

Research output: Contribution to journalArticlepeer-review

Abstract

We introduce the innovative use of technetium-99m–labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma with persistent congestion symptoms. Symptom resolution occurred with lenalidomide and steroids. This marks the first clinical use of technetium-99m–labeled macroaggregated albumin for clarifying high-output heart failure etiology.

Original languageEnglish (US)
Article number102387
JournalJACC: Case Reports
Volume29
Issue number14
DOIs
StatePublished - Jul 17 2024

Keywords

  • arteriovenous shunting
  • high-output heart failure
  • multiple myeloma
  • technetium-99m-labeled macroaggregated albumin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'High-Output Heart Failure in Multiple Myeloma: Novel Application of Tc-99m MAA to Identify Intramedullary Shunting'. Together they form a unique fingerprint.

Cite this